Photocure ASA

Norwegian specialty pharmaceutical company founded in 1997 in Oslo. Exclusively focused on bladder cancer through proprietary photodynamic technology. Product Cysview® (blue light cystoscopy) is the only FDA-approved product for use with blue light cystoscopy, causing cancerous lesions to fluoresce red for improved diagnosis. Listed on Oslo Stock Exchange. Collaborating with Asieris on EMA marketing authorization application for CEVIRA.